Clinical and research tests for C0345893 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First< Prev

Page 1 of 4

Results: 1 to 20 of 76

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
Expedio Hereditary Cancer Predisposition Screening Assay Kailos Genetics United States	40	31	C Sequence analysis of the entire coding region
Hereditary Cancer Screening - Colorectal & Gastric Cancer Panel (including Pancreatic Cancer) - (43 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States	58	43	X Mutation scanning of select exons
Hereditary Cancer Screening - Common Hereditary Cancer Panel (41 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States	47	41	X Mutation scanning of select exons
Hereditary Cancer Screening - Full Hereditary Cancer Panel (99 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States	109	99	X Mutation scanning of select exons
Cardiology Sequencing- Aortopathy Comprehensive Panel (24 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States	17	24	X Mutation scanning of select exons
Cardiology Sequencing- Full Panel (174 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States	122	174	X Mutation scanning of select exons
Otogenetics Hereditary Cancers Otogenetics United States	36	39	E Sequence analysis of select exons
Common Hereditary Cancer Screening Panel PreventionGenetics United States	94	55	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
myRisk Hereditary Cancer Myriad Genetics, Inc. United States	32	46	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Blood Coagulation Panel Centogene US, LLC - The Rare Disease Company United States	110	112	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
CentoDysmorph Panel Centogene US, LLC - The Rare Disease Company United States	740	728	D Deletion/duplication analysis C Sequence analysis of the entire coding region
CentoHear Panel Centogene US, LLC - The Rare Disease Company United States	203	194	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Connective Tissue and Related Disorder Panel Centogene US, LLC - The Rare Disease Company United States	75	76	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Pancreatitis Panel Centogene US, LLC - The Rare Disease Company United States	27	29	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Pulmonary Panel Centogene US, LLC - The Rare Disease Company United States	99	101	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
CentoNeuro Panel Centogene US, LLC - The Rare Disease Company United States	1886	1858	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Intellectual Disability Panel Centogene US, LLC - The Rare Disease Company United States	777	770	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
SMAD4 - MLPA Centogene US, LLC - The Rare Disease Company United States	4	1	D Deletion/duplication analysis
CentoColon Centogene US, LLC - The Rare Disease Company United States	67	33	D Deletion/duplication analysis C Sequence analysis of the entire coding region
CentoCancer Centogene US, LLC - The Rare Disease Company United States	114	68	D Deletion/duplication analysis C Sequence analysis of the entire coding region

<< First< Prev

Page 1 of 4

Results: 1 to 20 of 76

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.